Consistent with this result, wound healing assays confirmed that vimentin overexpression attenuated the inhibitory effect of fedratinib on ESCC cell migration (Figure 5B; Supplementary Figure S6B). This evidence concerns the gene VIM and esophageal squamous cell carcinoma.